Digital Health Startups

Optina develops a retinal imaging and AI platform for diagnosing and managing Age-Related Macular Degeneration in eye care specialists and patients. The platform combines hyperspectral imaging technology with AI clinical decision support to improve early detection and disease monitoring.

1 investor

Optina develops a retinal imaging and AI platform, combining an FDA 510(k) cleared hyperspectral camera with AI to help eye specialists diagnose and manage Age-Related Macular Degeneration and other retinal disease. The platform supports early, intermediate, and late-stage detection, risk monitoring, and tracking of therapeutic effectiveness in at-risk patients.

1 investor

Optivio is developing a biofeedback-based SaaS platform, preparing for launch with its first customers. The company operates in the life science and digital health space.

1 investor

Opus Medical provides personalized case management services for injured workers, matching clinical oversight to the severity of each injury. It supports workers and employers through the recovery process using clinical coordination and evidence-based practices, primarily in the workers' compensation context.

1 investor

Opyn provides a healthcare technology platform that unifies benefits, care navigation, virtual care, price transparency, provider intelligence, and service automation for health plan members, providers, and the administrative teams that support them. It aims to help members make informed care decisions while reducing manual work and costs for the teams operating health plans.

1 investor

OpZira develops wearable and diagnostic testing systems for the detection and monitoring of retinal and visual pathway diseases. The company serves eye care professionals and healthcare providers working with patients at risk for or diagnosed with ocular conditions.

1 investor

ORA is a digital health and wellness company offering telehealth and hybrid (virtual and in-person) consultations for chronic conditions, weight management, reproductive health, and aesthetics. It operates consumer brands andSons (men's health), OVA (women's health), and Modern Molecules (anti-ageing), serving patients primarily in Singapore.

1 investor

OraLiva develops an AI-powered, non-invasive oral cancer test designed to detect cancer early during routine dental visits, using single-cell analysis and microfluidic technologies. The company is advancing a point-of-care diagnostic device for dental networks, building on its current lab-developed platform.

1 investor

OraQ is an AI clinical decision support system for dental practices that applies risk intelligence to standardize exams, flag clinical risk early and support treatment planning. Based in Calgary, it works with dental practices across North America.

1 investor

Orb Health provides "Care Management as a Service," using remote, EMR-connected virtual contact centers staffed with licensed administrative and clinical agents to handle patient access, scheduling, and care coordination on behalf of providers. It serves health centers, hospitals, health systems, and unions across fee-for-service, capitated, and value-based care models.

1 investor

Orbita provides AI-driven patient engagement and communication software that automates workflows across the care journey, including scheduling, intake, procedure prep, and follow-up. It serves healthcare organizations, aiming to increase patient engagement and reduce staff workload.

1 investor

ORCHA provides digital health assurance and assessment services, validating health technologies against global standards for suppliers, health systems, and regulators worldwide.

1 investor

Orchestra Health provides software for streamlining preoperative care processes, helping surgical facilities reduce cancellations and improve patient outcomes. The platform serves surgeon offices and health systems performing orthopedic and spine procedures.

1 investor

Orfeostory is a web and mobile app development agency in Singapore that provides custom website design, development, and app creation services for businesses of various sizes. The company serves SMEs and corporate clients seeking web solutions ranging from e-commerce platforms to WordPress and PHP development.

1 investor

Organo-ID develops iPSC-derived organoid systems, including 3D hepatocyte models, to test drugs in better-modeled biological systems for predictive diagnostics and personalized therapies. The company serves drug development and treatment applications in oncology and rare disease, operating from Turkey with a global focus.

1 investor

Oriente is a fintech company providing mobile-first financial infrastructure and identity-based solutions for underserved consumers, small businesses, and merchants across Asia's fastest-growing economies. The company combines proprietary technology with partnerships to enable financial access and economic opportunity in emerging markets.

1 investor

Origin Medical develops a real-time AI assistant for prenatal ultrasound examinations that aims to shorten exam times, standardize workflows, and reduce errors. It serves sonographers, reading physicians, health systems, and private practices to improve the quality and consistency of prenatal scans and patient care.

1 investor

Origin Sciences applies a hologenomic approach integrating host genetics, epigenetics, and microbiome analysis into a single diagnostic framework for deeper health assessment. The company works with leading institutions and technology providers to develop and scale advanced diagnostic assays for clinical and research applications.

1 investor

Origin provides in-home pediatric speech, occupational, and physical therapy by matching families with local licensed therapists who visit the child's home, with sessions covered by insurance. It also serves as a marketplace for therapists to set their own schedules and build caseloads by choosing clients in their area.

1 investor

ORII develops a screen-free smartphone accessory that allows users to interact with their phones through voice and touch without relying on a display. Designed for accessibility, the device serves users who need or prefer screen-free alternatives to traditional touchscreen devices.

1 investor

Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.

1 investor

Orion Health builds a unified healthcare platform combining digital front-end and care record systems, serving healthcare providers and systems to improve care efficiency and patient outcomes through data insights and machine learning.

1 investor

Orreco combines AI with sports science to turn athlete data — including blood biomarkers, menstrual cycle tracking, and injury prediction — into actionable recovery and performance recommendations for elite athletes, pro teams, coaches, and doctors. Its products include Orreco.AI, FitrWoman, FitrCoach, and biomarker analytics platforms used across leagues such as the NBA, NFL, MLB, NHL, EPL, F1, and PGA Tour.

1 investor

Ortho BioMed combines expertise in medicine, engineering, and data science to develop medical technology solutions that improve patient outcomes.

1 investor